logo

BEAT

HeartBeam
--
--(--)
Market Open: --
--
--(--)
Post-Market: --

BEAT fundamentals

HeartBeam (BEAT) released its earnings on May 13, 2025: revenue was 0 (YoY 0.00%), beat estimates; EPS was -0.18 (YoY -5.88%), missed estimates.
Revenue / YoY
0
0.00%
EPS / YoY
-0.18
-5.88%
Report date
May 13, 2025
BEAT Earnings Call Summary for Q1,2025
  • FDA Clearance on Track: 12-lead synthesis software expected to clear by end-2025, enabling commercial launch. Engaging FDA on ischemia detection expansion.
  • Strategic Partnership Boost: AccurKardia algorithm integration enhances automated ECG analysis, filling key workflow gap for asymptomatic users.
  • Commercial Playbook Solidified: $50-$100/month pricing model, U.S. manufacturing to avoid tariffs, and 45K-patient initial target market via 2 sales reps.
  • Growth Catalysts Identified: $500M concierge cardiology market, 20M ischemia patients, and Medicare Advantage partnerships for reimbursement.
EPS
Revenue

Revenue & Expenses

Key Indicators

HeartBeam (BEAT) key financial stats and ratios, covering profitability, financial health, and leverage.
HeartBeam (BEAT)'s revenue and profit trends over recent years, visualized with a waterfall chart to showcase the revenue-to-profit funnel.
Trend
Breakdown
HeartBeam (BEAT)'s asset and liability trends over recent years, visualized with a waterfall chart to illustrate changes in its asset-liability structure.
Trend
Breakdown
HeartBeam (BEAT)'s cash flow trends over recent years, visualized with a waterfall chart to illustrate changes in its operating, investing, and financing cash flows.
Trend
Breakdown
Where does HeartBeam (BEAT) generate its revenue? Explore its key revenue streams and top earning regions.
By Business
Data source:
By Region
Data source:
Track HeartBeam (BEAT) Dividend Yield, Payout Ratio & Sustainability Through Its Dividend History
Payout Ratio
Dividend Yield